Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

The researchers chose to create a mouse atlas, partly because mouse tissue is smaller and much easier to access than human tissue, but also because mice are a common lab animal and can be easily manipulated genetically.

Barres at Stanford, for example, studies the neural cells that form myelin, an insulating sheath for neurons that degenerates in multiple sclerosis (MS). “We found using the atlas that some genes involved in myelin formation are only expressed in certain parts of the myelin,” says Barres. “It’s been known that MS affects some regions of the brain and not others, so these findings suggest a new hypothesis for what’s going on.” He plans to compare gene expression patterns to gene expression in a mouse that has been genetically engineered to have a disease similar to multiple sclerosis.

At Caltech, Anderson studies the amygdala, a brain area that plays a role in fear and anxiety and has also been implicated in autism, a developmental disorder characterized by cognitive and social problems. He says the amygdala is made up of several different parts that are difficult to distinguish with a microscope. Anderson says the brain atlas shows that these subregions have distinct patterns of gene expression. Now he and other researchers can look at the development of these specific areas, to see how they might be altered in autism.

Researchers at the Allen Institute are just beginning to mine the massive database of information they’ve generated. Nonetheless, they’ve already uncovered some interesting findings. “Approximately 80 percent of the genes in the genome are expressed in the brain, which is greater than the previous estimates of 60-70 percent,” says Kelly Overly, research alliance manager at the Allen Institute. “The genome is much more represented in the brain than we thought.”

She adds that the finding has implications for drug development: if scientists are developing new drugs that target gene products found in both the brain and body, they can try to avoid targeting areas not involved in the disease.

The institute is now planning a new project focusing on the neocortex, the brain area responsible for higher thought. They will use data from the mouse atlas, as well as from human tissue samples, to try to better understand the phenomenon of complex thought. Researchers are also collaborating with other institutions to study autism, epilepsy, and ALS. Comparing gene-expression patterns in the brain atlas with that of animal models of these diseases can shed light on exactly what’s gone awry.

“That information can be a huge help in focusing research efforts to understand diseases, as well as hopefully developing new and better therapeutics,” says the Allen Institute’s Overly.

0 comments about this story. Start the discussion »

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me
×

A Place of Inspiration

Understand the technologies that are changing business and driving the new global economy.

September 23-25, 2014
Register »